BGI Co-Win
Shenzhen, Guangdongbgi-cowin.com
Overview
BGI Co-Win, founded in 2016, is the corporate venture capital arm of BGI Group, based in Shenzhen, China . The firm invests in medical technology, gene technology, and biomedical companies . It targets early-stage industries, including biotechnology, healthcare IT, pharmaceuticals, and medical supplies .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| uBriGene Biosciences | Sep 2022 | Series C | Co-investor |
| EdiGene | Aug 2018 | Series A Extension | - |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.